Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

CRISPR Therapeutics AG(CRSP US)

$54.11+2.645.13%Ext:$53.80-0.310.57%(After Hours · 23:20:10 UTC)
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
CRSP US​
Ask AI

SEC Filings

Financials(40)

Expand
  • 10-QQ2ended 30 Jun 20263 Aug
  • 10-QQ1ended 31 Mar 20264 May
  • 10-KFY 2025ended 31 Dec 202512 Feb
  • 10-QQ3ended 30 Sept 202510 Nov 2025
  • 10-QQ2ended 30 Jun 20254 Aug 2025
  • 10-QQ1ended 31 Mar 20256 May 2025
  • 10-KFY 2024ended 31 Dec 202411 Feb 2025
  • 10-QQ3ended 30 Sept 20245 Nov 2024
  • 10-QQ2ended 30 Jun 20245 Aug 2024
  • 10-QQ1ended 31 Mar 20248 May 2024
  • 10-KFY 2023ended 31 Dec 202321 Feb 2024
  • 10-QQ3ended 30 Sept 20236 Nov 2023
  • 10-QQ2ended 30 Jun 20237 Aug 2023
  • 10-QQ1ended 31 Mar 20238 May 2023
  • 10-QQ3ended 30 Sept 20221 Nov 2022

Events(135)

Expand
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers19 Oct
  • 8-KResults of Operations and Financial Condition3 Aug
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers4 Jun
  • 8-KResults of Operations and Financial Condition4 May
  • 8-KEntry into a Material Definitive Agreement16 Mar
  • 8-KOther Events11 Mar
  • 8-KResults of Operations and Financial Condition12 Feb
  • 8-KOther Events12 Jan
  • 8-KResults of Operations and Financial Condition10 Nov 2025
  • 8-KOther Events15 Oct 2025
  • 8-KResults of Operations and Financial Condition4 Aug 2025
  • 8-KOther Events26 Jun 2025
  • 8-KCharter/Bylaw Amendment; Fiscal Year Change9 Jun 2025
  • 8-KEntry into Material Agreement19 May 2025
  • 8-KResults of Operations and Financial Condition6 May 2025

Insider Ownership(501)

Expand
  • 4Statement of changes in beneficial ownership05:41PM
  • 4Statement of changes in beneficial ownership05:39PM
  • 4Statement of changes in beneficial ownership05:38PM
  • 4Statement of changes in beneficial ownership05:37PM
  • 4Statement of changes in beneficial ownership21 Oct
  • 3Initial statement of beneficial ownership21 Oct
  • 4Statement of changes in beneficial ownership20 Oct
  • 4Statement of changes in beneficial ownership16 Oct
  • 4Statement of changes in beneficial ownership15 Oct
  • 4Statement of changes in beneficial ownership15 Oct
  • 4Statement of changes in beneficial ownership8 Oct
  • 4Statement of changes in beneficial ownership24 Sep
  • 4Statement of changes in beneficial ownership21 Sep
  • 4Statement of changes in beneficial ownership21 Sep
  • 4Statement of changes in beneficial ownership11 Aug

Beneficial Ownership(72)

Expand
  • SC 13G/ACRISPR Therapeutics AG14 Aug
  • SC 13G/ACRISPR Therapeutics AG27 Jul
  • SC 13G/ACRISPR Therapeutics AG15 May
  • SC 13GCRISPR Therapeutics AG14 May
  • SC 13G/ACRISPR Therapeutics AG30 Apr
  • SC 13G/ACRISPR Therapeutics AG17 Feb
  • SC 13G/ACRISPR Therapeutics AG5 Feb
  • SC 13GCRISPR Therapeutics AG14 Nov 2025
  • SC 13G/ACRISPR Therapeutics AG4 Nov 2025
  • SC 13GCRISPR Therapeutics AG17 Jul 2025
  • SC 13G/ACRISPR Therapeutics AG14 May 2025
  • SC 13G/ACRISPR Therapeutics AG13 May 2025
  • SC 13G/ACRISPR Therapeutics AG14 Feb 2025
  • SC 13G/ACRISPR Therapeutics AG10 Jan 2025
  • SC 13G/ACRISPR Therapeutics AG10 Dec 2024

Other Ownership(20)

Expand
  • 144George Simeon14 Oct
  • 144KASINGER JAMES R.6 Oct
  • 144KASINGER JAMES R.22 Sep
  • 144Behbahani Ali17 Sep
  • 144Kulkarni Samarth22 Jan
  • 144Prasad Raju22 Jan
  • 144Kulkarni Samarth20 Jan
  • 144Prasad Raju6 Jan
  • 144Prasad Raju22 Dec 2025
  • 144Kulkarni Samarth18 Feb 2025
  • 144Kulkarni Samarth12 Nov 2024
  • 144Kulkarni Samarth15 Apr 2024
  • 144Morrow Phuong Khanh22 Mar 2024
  • 144Kulkarni Samarth15 Mar 2024
  • 144Kulkarni Samarth15 Feb 2024

Proxies(38)

Expand
  • ARSAnnual report to security holders21 Apr
  • DEFA14ADefinitive additional materials21 Apr
  • DEF 14ADefinitive proxy statement21 Apr
  • PRE 14APreliminary proxy statement2 Apr
  • ARSAnnual report to security holders16 Apr 2025
  • DEFA14ADefinitive additional materials16 Apr 2025
  • DEF 14ADefinitive proxy statement16 Apr 2025
  • PRE 14APreliminary proxy statement3 Apr 2025
  • ARSAnnual report to security holders9 Apr 2024
  • DEF 14ADefinitive proxy statement9 Apr 2024
  • DEFA14ADefinitive additional materials9 Apr 2024
  • PRE 14APreliminary proxy statement27 Mar 2024
  • DEFA14ADefinitive additional materials18 May 2023
  • ARSAnnual report to security holders26 Apr 2023
  • DEF 14ADefinitive proxy statement26 Apr 2023

Registrations(42)

Expand
  • S-8Registration statement (employee benefit plan)5 Jun
  • 424B5Prospectus filing (Rule 424(b)(5))15 Oct 2025
  • 424B5Prospectus filing (Rule 424(b)(5))19 May 2025
  • S-3ASRAutomatic shelf registration statement (S-3)5 Aug 2024
  • S-8Registration statement (employee benefit plan)5 Aug 2024
  • 424B5Prospectus filing (Rule 424(b)(5))13 Feb 2024
  • S-8Registration statement (employee benefit plan)7 Aug 2023
  • S-8Registration statement (employee benefit plan)8 Aug 2022
  • S-3ASRAutomatic shelf registration statement (S-3)29 Jul 2021
  • 424B5Prospectus filing (Rule 424(b)(5))15 Jan 2021
  • 424B5Prospectus filing (Rule 424(b)(5))11 Dec 2020
  • S-8Registration statement (employee benefit plan)27 Jul 2020
  • 424B5Prospectus filing (Rule 424(b)(5))1 Jul 2020
  • 424B5Prospectus filing (Rule 424(b)(5))29 Jun 2020
  • 424B5Prospectus filing (Rule 424(b)(5))21 Nov 2019

Filing Review Correspondence(9)

Expand
  • CORRESPFiling review correspondence23 Jun 2022
  • CORRESPFiling review correspondence29 Apr 2019
  • CORRESPFiling review correspondence23 Apr 2019
  • CORRESPFiling review correspondence1 Dec 2017
  • CORRESPFiling review correspondence1 Dec 2017
  • CORRESPFiling review correspondence14 Oct 2016
  • CORRESPFiling review correspondence14 Oct 2016
  • CORRESPFiling review correspondence9 Sep 2016
  • DRSLTRFiling review correspondence (DRSLTR)2 Sep 2016

SEC Orders And Notices(6)

Expand
  • CT ORDERConfidential treatment order30 Nov 2018
  • CT ORDERConfidential treatment order21 Dec 2017
  • EFFECTNotice of effectiveness4 Dec 2017
  • CT ORDERConfidential treatment order13 Jan 2017
  • CT ORDERConfidential treatment order18 Oct 2016
  • EFFECTNotice of effectiveness18 Oct 2016

Exempt Offerings(3)

Expand
  • D/A06b10 Apr 2020
  • D06b9 Apr 2020
  • D06c4 Nov 2016

Other(1)

Expand
  • CERTNASAUTO-GENERATED PAPER DOCUMENT18 Oct 2016